Esomeprazole Magnesium Patent Expiration
Esomeprazole Magnesium was first introduced by Astrazeneca Pharmaceuticals Lp
Esomeprazole Magnesium Patents
Given below is the list of patents protecting Esomeprazole Magnesium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Esomeprazole Magnesium | US10076494 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Esomeprazole Magnesium | US10835488 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
| Nexium | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca |
| Nexium |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca |
| Nexium | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca |
| Nexium |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca |
| Nexium | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca |
| Nexium |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca |
| Nexium | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca |
| Nexium |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca |
| Nexium | US6147103 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium |
US6147103 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium | US6166213 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium |
US6166213 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium | US6191148 | Omerazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
| Nexium |
US6191148 (Pediatric) | Omerazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
| Nexium | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca |
| Nexium |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca |
| Nexium | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca |
| Nexium |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca |
| Nexium | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium | US8466175 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
| Nexium |
US8466175 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
| Nexium 24hr | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US7411070 | Form of S-omeprazole |
May 18, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 18, 2018
(Expired) | Astrazeneca Lp |
| Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Esomeprazole Magnesium's patents.
Latest Legal Activities on Esomeprazole Magnesium's Patents
Given below is the list recent legal activities going on the following patents of Esomeprazole Magnesium.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
| Recordation of Patent Grant Mailed | 17 Nov, 2020 | US10835488 |
| Patent Issue Date Used in PTA Calculation | 17 Nov, 2020 | US10835488 |
| Email Notification | 29 Oct, 2020 | US10835488 |
| Issue Notification Mailed | 28 Oct, 2020 | US10835488 |
| Email Notification | 13 Oct, 2020 | US10835488 |
| Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
| Dispatch to FDC | 10 Oct, 2020 | US10835488 |
| Corrected Notice of Allowability | 07 Oct, 2020 | US10835488 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Esomeprazole Magnesium Generics
Several generic applications have been filed for Esomeprazole Magnesium. The first generic version for Esomeprazole Magnesium was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jan 26, 2015. And the latest generic version is by Glenmark Specialty Sa and was approved on Jun 11, 2024.
Given below is the list of companies who have filed for Esomeprazole Magnesium generic.
1. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 24, 2022 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 19, 2021 |
2. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 2, 2020 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jun 2, 2020 |
3. LANNETT CO INC
Lannett Co Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 1, 2017 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 1, 2017 |
4. MARKSANS PHARMA
Marksans Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Marksans Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Sep 29, 2023 |
5. CISEN
Cisen Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cisen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 22, 2020 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 22, 2020 |
6. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 26, 2015 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 26, 2015 |
7. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Oct 16, 2017 |
8. INDCHEMIE HEALTH
Indchemie Health Specialties Pvt Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Indchemie Health.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 26, 2021 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Feb 26, 2021 |
9. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 19, 2015 |
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 19, 2015 |
10. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
| EQ 20MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
| EQ 10MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Mar 23, 2020 |
11. HEC PHARM
Hec Pharm Usa Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hec Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | May 18, 2018 |
| EQ 20MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | May 18, 2018 |
12. AMNEAL PHARMS NY
Amneal Pharmaceuticals Of Ny Llc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 5, 2019 |
| EQ 40MG BASE | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Apr 10, 2019 |
13. ZHEJIANG YONGTAI
Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 27, 2023 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 27, 2023 |
14. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 22, 2019 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 22, 2019 |
| EQ 20MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Jun 7, 2023 |
| EQ 40MG BASE/PACKET | for suspension, delayed release | Prescription | ORAL | AB | Jun 7, 2023 |
15. ETHYPHARM
Ethypharm Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ethypharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 31, 2021 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 31, 2021 |
16. P AND L
P And L Development Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Discontinued | ORAL | N/A | Mar 5, 2019 |
17. GUARDIAN DRUG
Guardian Drug Co has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Guardian Drug.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Mar 15, 2023 |
18. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 28, 2023 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Mar 28, 2023 |
19. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | May 10, 2019 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Jun 11, 2024 |
20. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet, delayed release | Over the counter | ORAL | N/A | Jun 25, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 3, 2015 |
21. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 25, 2015 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Apr 30, 2024 |
22. CSPC OUYI
Cspc Ouyi Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 2, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 2, 2020 |
23. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 21, 2016 |
| EQ 20MG BASE | tablet, delayed release | Over the counter | ORAL | N/A | Jul 12, 2023 |
24. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 30, 2018 |
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | May 4, 2020 |
25. GUANGZHOU NOVAKEN
Guangzhou Novaken Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Guangzhou Novaken.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 18, 2020 |
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 18, 2020 |
26. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 20, 2017 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 20, 2017 |
27. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule, delayed release | Over the counter | ORAL | N/A | Aug 18, 2017 |
28. GRANULES
Granules India Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 18, 2023 |
| EQ 20MG BASE | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 18, 2023 |